Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-11-000014
Filing Date
2011-08-15
Accepted
2011-08-15 16:04:14
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-063011.htm 10-Q 652438
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 16114
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 16255
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 6183
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 6193
  Complete submission text file 0000318306-11-000014.txt   2299305

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT accp-20110630.xml EX-101.INS 268182
7 XBRL TAXONOMY SCHEMA accp-20110630.xsd EX-101.SCH 12216
8 XBRL TAXONOMY CALCULATION LINKBASE accp-20110630_cal.xml EX-101.CAL 36962
9 XBRL TAXONOMY DEFINITION LINKBASE accp-20110630_def.xml EX-101.DEF 18062
10 XBRL TAXONOMY LABEL LINKBASE accp-20110630_lab.xml EX-101.LAB 165245
11 XBRL TAXONOMY PRESENTATION LINKBASE accp-20110630_pre.xml EX-101.PRE 97804
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 111036238
SIC: 2834 Pharmaceutical Preparations